Establishment Labs Shifts CFO as It Preps for Growth Phase
Event summary
- Raj Denhoy moves from CFO to SVP of Global Strategy on March 9, 2026.
- Cassandra 'Sandra' Harris appointed as new Senior Vice President and CFO.
- Harris brings experience from Genesco Inc., Artisan Design Group, and Tupperware Brands.
- Denhoy will focus on growth accelerators and strategic initiatives.
The big picture
Establishment Labs is restructuring its executive team to support its next phase of growth, reflecting confidence in its business model. The shift aligns with broader trends in medical technology companies prioritizing strategic leadership as they scale. With a focus on breast aesthetics and reconstruction, the company aims to accelerate initiatives that drive highly profitable growth.
What we're watching
- Leadership Impact
- How Sandra Harris’s retail and turnaround experience translates to medical tech.
- Growth Strategy
- Whether Raj Denhoy’s strategic focus can drive profitable expansion.
- Operational Momentum
- The pace at which Establishment Labs scales its leadership capacity for new initiatives.